Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Investigation of the PREVENTIA® Irrigation Solution for Reducing Bacteria in Spinal Surgery With Implants - A Comparative Study

Spinal surgery carries a risk of surgical wound infections (i.e., the entry of bacteria). Despite various preventive measures, such infections continue to occur, particularly in operations involving implants. In this study, we would like to investigate whether rinsing the surgical wound with a special irrigation solution called PREVENTIA® can reduce the number of bacteria in the wound during the operation.

Participants needed: 114
Trial details
Phase: Phase 4Age: 18+Biological sex: MaleType: InterventionalSponsor: Universität LuzernUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Age more than 18 years [+2]

Emergency spine surgery [+8]

Status: Not yet recruiting

Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery

The goal of this clinical trial is to find out if a gut cleaning using Rifaximin works as well as the usual treatment with Neomycin and Metronidazole to prevent infections after colon surgery. The study includes adult patients who will have colon surgery. The main question it aims to answer are: -Does the Rifaximin treatment prevent surgical site infections as well as the Neomycin/Metronidazole treatment? Other things the study will look at: * How often infections happen, stratified on how deep they are, the type of surgery the patients got, or if bowel cleaning was done before surgery. * How many people will die after surgery * How long people stay in hospital Participants will: * Take either Rifaximin or Neomycin/Metronidazole one day before surgery to clean their gut * Keep a diary until the surgery to record medication intake and any side effects * Be contacted by phone 30 days after surgery to ask about their condition and any side effects,

Participants needed: 458
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Universität LuzernUpdated: Sep 18, 2025Locations: 4
Eligibility criteria

aged ≥ 18 years [+3]

contraindications and/or intolerance to one of the study compounds [+3]